Acquisition / mergerNotable· Adverse for the businessFiled on BSE ·

Emami Ltd reports Q4FY26 results with 4% revenue decline and key strategic investments

Emami · Personal Products

Arthneeti Research DeskPublished 1 min read
₹925 CrAcquisition / merger

Key highlights

  • Q4FY26 consolidated revenue from operations declined 4% to ₹925 crore; PAT ₹143 crore
  • FY26 revenue ₹3,780 crore; EBITDA ₹964 crore; PAT ₹775 crore; interim dividends of ₹10/share totaling ₹436.5 crore declared
  • Increased stake in Axiom Ayurveda (subsidiary from 1 April 2026) and acquiring majority stake in IncNut digital brands

Why it's rated notable: the year-on-year change is 12% (10% to 20% for adverse news)

Original filing

Announcement under Regulation 30 (LODR)-Press Release / Media Release

Read the filing on BSE (PDF) →

Companies guiding to strong growth

Ranked by management's own guidance on revenue and margins — not by us.

Rossell Techsys

Aerospace & Defense

Revenue growth 40%+Margin up 2%+

Sign up free to see all 6 →

See full rankings

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

More from Emami

Other acquisition / merger filings this fortnight

All acquisition / merger filings →

Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.